AMPHETAMINE REGULATION OF MESOLIMBIC DOPAMINE CHOLECYSTOKININ NEUROTRANSMISSION

被引:49
作者
HURD, YL
LINDEFORS, N
BRODIN, E
BRENE, S
PERSSON, H
UNGERSTEDT, U
HOKFELT, T
机构
[1] KAROLINSKA INST, DEPT PHARMACOL, S-10401 STOCKHOLM 60, SWEDEN
[2] KAROLINSKA INST, DEPT MED CHEM, S-10401 STOCKHOLM 60, SWEDEN
[3] KAROLINSKA INST, MOLEC BIOL LAB, S-10401 STOCKHOLM 60, SWEDEN
[4] KAROLINSKA INST, DEPT HISTOL, S-10401 STOCKHOLM 60, SWEDEN
关键词
NUCLEUS ACCUMBENS; RAT; INVIVO MICRODIALYSIS; MESSENGER RNA; FLUOROGOLD;
D O I
10.1016/0006-8993(92)90264-A
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of acute and repeated amphetamine administration on mesolimbic dopamine (DA) neurons was assessed by studying DA and cholecystokinin (CCK) release in the nucleus accumbens (Acc), as well as effects on mRNA genes regulating DA and CCK synthesis in ventral tegmental area (VTA) cells in rats. Amphetamine (1.5 mg/kg) markedly increased extracellular levels of DA in the medial Acc (assessed by in vivo microdialysis) in drug-naive animals, about twice the amount released in animals repeatedly administered the drug for the previous 7 days (twice daily). CCK overflow was found to mirror the DA responses in that the very transient elevation of CCK monitored in drug-naive animals was attenuated in those with prior amphetamine use. The attenuation of both DA and CCK overflow in the medial Acc was found to be associated with a decrease in the number of CCK mRNA-positive VTA neurons (assessed by in situ hybridization histochemistry). Although the number of cells expressing CCK mRNA were decreased, the gene expression in those positive CCK and tyrosine hydroxylase mRNA cells in the VTA was significantly increased. The CCK mRNA neurons in the VTA were positively identified as those projecting to the medial Acc by the local perfusion of Fluoro-gold retrograde tracer via microdialysis probes located in the Acc.
引用
收藏
页码:317 / 326
页数:10
相关论文
共 55 条
  • [1] CHOLECYSTOKININ ATTENUATES BASAL AND DRUG-INDUCED INCREASES OF LIMBIC AND STRIATAL DOPAMINE RELEASE
    ALTAR, CA
    BOYAR, WC
    OEI, E
    WOOD, PL
    [J]. BRAIN RESEARCH, 1988, 460 (01) : 76 - 82
  • [2] CHOLECYSTOKININ - CORELEASE WITH DOPAMINE FROM NIGROSTRIATAL NEURONS IN THE CAT
    ARTAUD, F
    BARUCH, P
    STUTZMANN, JM
    SAFFROY, M
    GODEHEU, G
    BARBEITO, L
    HERVE, D
    STUDLER, JM
    GLOWINSKI, J
    CHERAMY, A
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1989, 1 (02) : 162 - 171
  • [3] DOPAMINE MAY INFLUENCE STRIATAL GABA RELEASE VIA 3 SEPARATE MECHANISMS
    BERNATH, S
    ZIGMOND, MJ
    [J]. BRAIN RESEARCH, 1989, 476 (02) : 373 - 376
  • [4] Bjorklund A., 1984, HDB CHEM NEUROANATOM, V2, P55
  • [5] BRODIN E, 1983, ACTA PHYSIOL SCAND, P17
  • [6] INVIVO STUDIES ON THE ENHANCEMENT OF CHOLECYSTOKININ RELEASE IN THE RAT STRIATUM BY DOPAMINE DEPLETION
    BUTCHER, SP
    VARRO, A
    KELLY, JS
    DOCKRAY, GJ
    [J]. BRAIN RESEARCH, 1989, 505 (01) : 119 - 122
  • [7] AMPHETAMINE, COCAINE, PHENCYCLIDINE AND NOMIFENSINE INCREASE EXTRACELLULAR DOPAMINE CONCENTRATIONS PREFERENTIALLY IN THE NUCLEUS ACCUMBENS OF FREELY MOVING RATS
    CARBONI, E
    IMPERATO, A
    PEREZZANI, L
    DICHIARA, G
    [J]. NEUROSCIENCE, 1989, 28 (03) : 653 - 661
  • [8] CHIUEH CC, 1975, J PHARMACOL EXP THER, V192, P642
  • [9] CONWAY PG, 1982, J PHARMACOL EXP THER, V221, P650
  • [10] DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1